Cytomegalovirus Retinitis in the Modern Era of Solid Organ Transplantation
Transplantation Proceedings · 2024
DOI: 10.1016/j.transproceed.2024.08.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Sias J Scherger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE, USA; Department of Medicine, Division of I…. Hauptthemen laut MEDLINE: Cytomegalovirus Retinitis, Organ Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NCATS.
Abstract (Originalsprache)
BACKGROUND: Cytomegalovirus retinitis (CMVR) is a well-described complication of CMV disease in immunocompromised hosts. While robust data exists for CMVR in patients with acquired immunodeficiency syndrome (AIDS), the incidence and risk factors for CMVR in solid organ transplant recipients (SOTR) with CMV viremia are less defined. METHODS: We performed a retrospective cohort study of SOTR who had CMV viremia and underwent routine ophthalmologic examination between 1/1/2018 and 3/16/2022. Univariate statistics were performed to evaluate risk factors for development of CMVR. RESULTS: Overall, 38 patients were included, primarily kidney (78.9%), heart (7.9%), and liver (7.9%) transplant recipients. Five patients (13.2%) developed CMVR during the study period. CMVR was diagnosed an average 281 days after index transplantation, 84 days from the most recent rejection episode, and 69 days from onset of viremia. Only 1 patient (20%) had symptoms at the time of CMVR diagnosis. CMVR was associated with preceding allograft rejection as well as transplanted organ type. CONCLUSION: While CMV tissue disease more commonly manifests in other organs, CMVR occurred relatively frequently in this group of high-risk SOTR with CMV viremia. As most of the patients in our study did not have ocular symptoms at the time of diagnosis, routine ophthalmologic screening should be considered in SOTR with CMV viremia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE, USA; Department of Medicine, Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Au…
- Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA; Department of Pharmacy, Scripps Health, La Jolla, CA, USA.
- Department of Ophthalmology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA.
- Department of Medicine, Icahn School of Medicine at Mt. Sinai, Division of Infectious Diseases, New York, NY, USA.
Förderung
- NCATS NIH HHS
- NCATS
Zitieren
APA
Scherger, S. J., Molina, K. C., Palestine, A. G., Pecen, P. E., & Bajrovic, V. (2024). Cytomegalovirus Retinitis in the Modern Era of Solid Organ Transplantation. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.08.007
Vancouver
Scherger SJ, Molina KC, Palestine AG, Pecen PE, Bajrovic V. Cytomegalovirus Retinitis in the Modern Era of Solid Organ Transplantation. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.08.007
BibTeX
@article{Scherger2024,
author = {Scherger, Sias J and Molina, Kyle C and Palestine, Alan G and Pecen, Paula E and Bajrovic, Valida},
title = {Cytomegalovirus Retinitis in the Modern Era of Solid Organ Transplantation},
journal = {Transplantation Proceedings},
year = {2024},
doi = {10.1016/j.transproceed.2024.08.007}
}
EUVIMED